The Pharma Data

APRIL 14, 2021

Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. with Xolair since its initial approval in 2003. today announced that the U.S. indications. In the U.S., Pulmozyme ® ?(dornase?alfa)

FDA Approval 52

FDA Approval Clinical Development FDA Licensing 52

Drug Discovery World

OCTOBER 16, 2023

Next, Saleko highligts how Northumberland and the North East of the UK are recognised for pharmaceutical manufacturing prowess. Situated at Surrey University science park and listed on London’s AIM Market since 2003, the market has provided long term support for growing healthcare companies. billion in funding.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

The Pharma Data

NOVEMBER 5, 2020

X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Most recently, Holland served as Global Head of licensing at Lonza AG. from 1993 to 1995. Dillon is a former St.

Analytical Chemistry 40

Analytical Chemistry Pharmaceuticals Small Molecule Therapies 40